Roshdy E., Řezníčková E., Elbadawi MM., Veselá D., Vojáčková V., Krňávková P., Kryštof V., Eldehna WM., Abe M. First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents. JOURNAL OF MEDICINAL CHEMISTRY. 2026.

Dayal N., Řezníčková E., Hernandez DE., Peřina M., Bělíček J., Vojáčková V., Krňávková P., Bařina M., Jorda R., Sintim HO. 3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2026.

Eldehna WM., Tawfik HO., Veselá D., Vojáčková V., Krňávková P., Kryštof V., Abdel-Aziz HA. Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum Cytotoxicity. Pharmaceuticals. 2025.

Cabezas D., Delgado T., Sepúlveda G., Krňávková P., Vojáčková V., Kryštof V., Strnad M., Mella J. 3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib. Pharmaceuticals. 2025.